Helen Stephenson-Ellis
Corporate Officer/Principal presso Chartered Institute of Personnel & Development
Profilo
Helen Stephenson-Ellis is a professional with experience in human resources.
She is currently a member of the Chartered Institute of Personnel & Development.
Previously, she worked as a Director of Human Resources at AstraZeneca PLC and Ligand UK Ltd.
She also served as the Chief People Officer at Oxford Biomedica Plc from 2018 to 2022.
Additionally, she was the Head of Human Resources at Medimmune UK Ltd.
Ms. Stephenson-Ellis obtained an undergraduate degree from the University of Northumbria.
Posizioni attive di Helen Stephenson-Ellis
| Società | Posizione | Inizio |
|---|---|---|
| Chartered Institute of Personnel & Development | Corporate Officer/Principal | - |
Precedenti posizioni note di Helen Stephenson-Ellis
| Società | Posizione | Fine |
|---|---|---|
| OXFORD BIOMEDICA PLC | Human Resources Officer | 01/05/2022 |
| VERNALIS | Human Resources Officer | - |
Medimmune UK Ltd.
 Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Human Resources Officer | - |
| ASTRAZENECA PLC | Human Resources Officer | - |
Formazione di Helen Stephenson-Ellis
| University of Northumbria | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Medimmune UK Ltd.
Medimmune UK Ltd. Chemicals: Major DiversifiedProcess Industries Medimmune UK Ltd. manufactures chemical products. The company was founded on October 6, 1999 and is headquartered in Speke, the United Kingdom. | Process Industries |
- Borsa valori
- Insiders
- Helen Stephenson-Ellis
